- 4-Week # shares sold: 2,000
- 12-Week # shares sold: 2,000
- 24-Week # shares sold: 13,250
Despite tepid market reaction, and analyst skepticism, there might be some upside for TMO.
Thermo Fisher Scientific (TMO) has reportedly offered $30 billion to acquire Illumina (ILMN).
Illumina is in breakout mode and could be headed much higher.